PDF herunterladen
Thromb Haemost 2003; 89(05): 944-945
DOI: 10.1055/s-0037-1613483
Letters to the Editor
Schattauer GmbH

A rebuttal: Cross-linking of fibrinogen by factor XIII zymogen is not apparent in vivo

Kevin R. Siebenlist
Weitere Informationen

Publikationsverlauf

Reiceved 25. Februar 2003

Accepted 28. Februar 2003

Publikationsdatum:
09. Dezember 2017 (online)

  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Siebenlist KR, Meh DA, Mosesson MW.. Protansglutaminase (Factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 2001; 86: 1221-8.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Siebenlist KR, Mosesson MW, Meh DA, DiOrio JP, Albrecht RM, Olson JD.. Coexisting dysfibrinogenemia (γR275C) and factor V Leiden deficiency associated with throm-boembolic disease (Fibrinogen Cedar Rapids). Blood Coagul Fibrinolysis 2000; 11: 293-304.
    PubMedGoogle Scholar
  • 3 Yee VC, Pederson LC, Bishop PD, Stenkamp RE, Teller DC.. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res 1995; 78: 389-97.
    CrossrefPubMedGoogle Scholar
  • 4 Polgár J, Hidasi V, Muszbek L.. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 1990; 267: 557-60.
    CrossrefPubMedGoogle Scholar
  • 5 Muszbek L, Yee VC, Hevessy Z.. Blood coagulation factor XIII. Structure and function. Thromb Res 1999; 94: 271-305.
    CrossrefPubMedGoogle Scholar
  • 6 Credo RB, Curtis CG, Lorand L.. Ca2+-related regulatory function of fibrinogen. Proc Natl Acad Sei (USA) 1978; 75: 4234-7.
    CrossrefPubMedGoogle Scholar
  • 7 Blombäck B, Procyk R, Adamson L, Hessel B.. FXIII Induced gelation of human fibrinogen - An alternative thiol enhanced, thrombin independent pathway. Thromb Res 1985; 37: 613-28.
    CrossrefPubMedGoogle Scholar